1st Quarter - Report
THE NICKLES GROUP, LLC for EMERGENT BIOSOLUTIONS
Client
Income
$40,000
Expenses
—
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DONALD KENT | — |
Budget/Appropriations BUD
Appropriations funding for FY 2022.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DONALD KENT | — |
Defense DEF
NDAA - provisions related to biological and chemical defense.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DONALD KENT | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.